MetaCap

Heartbeam (BEAT) vs PAVmed (PAVM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Heartbeam (BEAT) has outperformed PAVmed (PAVM) over the past year, losing 69.1% versus a loss of 81.2%. Heartbeam is the larger company by market cap ($27.5 million vs $21.5 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BEAT-69.15%PAVM-81.21%
+104%+7%-91%
Oct 7, 20251 yearOct 7, 2026
BEAT-87.22%PAVM-99.88%
+43%-32%-107%
Nov 8, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BEAT versus PAVM key metrics
MetricBEATPAVM
Share price$0.4887$2.69
Market cap$27.54M$21.51M
1-day change-10.00%-1.82%
YTD return-77.38%-58.67%
1-year return-69.15%-81.21%
5-year return—-99.90%
EPS (TTM)$-0.50$-14.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$4.00$28.44
52-week low$0.355$2.60
Distance from 52-week high-87.78%-90.54%
Average volume7.32M30.46K
Shares outstanding56.35M8.00M
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BEAT has outperformed PAVM by 12.1 percentage points over the past year.

BEAT vs PAVM FAQ

Which is bigger, Heartbeam or PAVmed?

Heartbeam (BEAT) is larger, with a market capitalization of $27.54M compared with $21.51M for PAVmed (PAVM).

Which stock has performed better over the past year, BEAT or PAVM?

BEAT returned -69.15% over the past 12 months, compared with -81.21% for PAVM (price return, excluding dividends). Past performance does not predict future results.

Are Heartbeam and PAVmed in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons